From: Dietary flavonoid intake and cardiovascular risk: a population-based cohort study
First tertile | Second tertile | Third tertile | |||||
---|---|---|---|---|---|---|---|
Total flavonoids | |||||||
Incident CV events | 54 | 40 | 31 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.65 | 0.42–0.99 | 0.05 | 0.45 | 0.28–0.73 | 0.001 |
Model 2 | 1 | 0.64 | 0.42–1.00 | 0.05 | 0.46 | 0.28–0.75 | 0.002 |
CV mortality | 34 | 26 | 24 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.97 | 0.56–1.67 | 0.90 | 0.81 | 0.45–1.44 | 0.47 |
Model 2 | 1 | 0.95 | 0.54–1.66 | 0.85 | 0.83 | 0.46–1.51 | 0.55 |
All-cause mortality | 89 | 69 | 62 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.86 | 0.62–1.21 | 0.38 | 0.73 | 0.51–1.04 | 0.08 |
Model 2 | 1 | 0.90 | 0.65–1.26 | 0.52 | 0.78 | 0.55–1.13 | 0.19 |
Proanthocyanids | |||||||
Incident CV events | 57 | 37 | 31 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.56 | 0.36–0.86 | 0.01 | 0.42 | 0.26–0.68 | <0.001 |
Model 2 | 1 | 0.56 | 0.36–0.87 | 0.009 | 0.43 | 0.27–0.70 | 0.001 |
CV mortality | 34 | 27 | 23 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.99 | 0.58–1.70 | 0.97 | 0.77 | 0.43–1.39 | 0.39 |
Model 2 | 1 | 0.98 | 0.56–1.69 | 0.93 | 0.80 | 0.44–1.46 | 0.46 |
All-cause mortality | 90 | 70 | 60 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.85 | 0.61–1.19 | 0.35 | 0.69 | 0.48–0.99 | 0.05 |
Model 2 | 1 | 0.88 | 0.63–1.24 | 0.46 | 0.75 | 0.52–1.08 | 0.12 |
Flavan-3-ols | |||||||
Incident CV events | 57 | 42 | 26 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.69 | 0.46–1.05 | 0.08 | 0.40 | 0.25–0.65 | <0.001 |
Model 2 | 1 | 0.71 | 0.47–1.08 | 0.11 | 0.42 | 0.26–0.68 | <0.001 |
CV mortality | 37 | 23 | 24 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.75 | 0.44–1.29 | 0.30 | 0.70 | 0.40–1.20 | 0.19 |
Model 2 | 1 | 0.79 | 0.46–1.37 | 0.40 | 0.72 | 0.41–1.26 | 0.25 |
All-cause mortality | 92 | 71 | 57 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.84 | 0.61–1.15 | 0.27 | 0.63 | 0.44–0.89 | 0.009 |
Model 2 | 1 | 0.86 | 0.62–1.19 | 0.36 | 0.68 | 0.48–0.96 | 0.03 |
Anthocyanidins | |||||||
Incident CV events | 53 | 35 | 37 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.59 | 0.38–0.92 | 0.02 | 0.58 | 0.37–0.92 | 0.02 |
Model 2 | 1 | 0.58 | 0.37–0.91 | 0.02 | 0.56 | 0.36–0.89 | 0.02 |
CV mortality | 40 | 20 | 24 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.58 | 0.33–1.01 | 0.05 | 0.65 | 0.37–1.15 | 0.14 |
Model 2 | 1 | 0.56 | 0.32–0.98 | 0.04 | 0.67 | 0.38–1.18 | 0.16 |
All-cause mortality | 95 | 62 | 63 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.69 | 0.50–0.96 | 0.03 | 0.66 | 0.47–0.94 | 0.02 |
Model 2 | 1 | 0.66 | 0.47–0.94 | 0.02 | 0.66 | 0.46–0.95 | 0.02 |
Flavanones | |||||||
Incident CV events | 54 | 42 | 29 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.71 | 0.47–1.07 | 0.11 | 0.45 | 0.28–0.73 | 0.001 |
Model 2 | 1 | 0.73 | 0.48–1.10 | 0.13 | 0.48 | 0.29–0.77 | 0.003 |
CV mortality | 39 | 24 | 21 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.67 | 0.40–1.13 | 0.14 | 0.56 | 0.32–0.99 | 0.05 |
Model 2 | 1 | 0.71 | 0.42–1.20 | 0.20 | 0.66 | 0.37–1.17 | 0.15 |
All-cause mortality | 91 | 80 | 49 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.91 | 0.67–1.24 | 0.54 | 0.54 | 0.37–0.78 | 0.001 |
Model 2 | 1 | 0.94 | 0.68–1.29 | 0.69 | 0.59 | 0.40–0.85 | 0.005 |
Flavonols | |||||||
Incident CV events | 56 | 31 | 38 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.49 | 0.31–0.76 | 0.002 | 0.53 | 0.34–0.83 | 0.006 |
Model 2 | 1 | 0.51 | 0.32–0.80 | 0.003 | 0.53 | 0.34–0.83 | 0.005 |
CV mortality | 36 | 22 | 26 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.63 | 0.36–1.09 | 0.10 | 0.68 | 0.39–1.19 | 0.18 |
Model 2 | 1 | 0.69 | 0.40–1.20 | 0.19 | 0.72 | 0.41–1.27 | 0.26 |
All-cause mortality | 91 | 64 | 65 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.72 | 0.51–1.00 | 0.05 | 0.70 | 0.50–0.99 | 0.05 |
Model 2 | 1 | 0.78 | 0.55–1.08 | 0.14 | 0.72 | 0.51–1.02 | 0.06 |
Flavones | |||||||
Incident CV events | 42 | 51 | 32 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 1.13 | 0.74–1.72 | 0.56 | 0.68 | 0.41–1.10 | 0.11 |
Model 2 | 1 | 1.14 | 0.75–1.75 | 0.54 | 0.66 | 0.40–1.09 | 0.10 |
CV mortality | 30 | 31 | 23 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 1.08 | 0.64–1.82 | 0.77 | 0.87 | 0.48–1.56 | 0.63 |
Model 2 | 1 | 1.10 | 0.65–1.87 | 0.72 | 0.83 | 0.45–1.52 | 0.55 |
All-cause mortality | 88 | 71 | 61 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.79 | 0.57–1.09 | 0.16 | 0.71 | 0.50–1.01 | 0.06 |
Model 2 | 1 | 0.83 | 0.60–1.16 | 0.28 | 0.73 | 0.51–1.05 | 0.09 |
Isoflavones | |||||||
Incident CV events | 48 | 38 | 39 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.78 | 0.51–1.20 | 0.26 | 0.77 | 0.49–1.19 | 0.23 |
Model 2 | 1 | 0.81 | 0.53–1.25 | 0.35 | 0.77 | 0.49–1.21 | 0.26 |
CV mortality | 30 | 34 | 20 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 1.23 | 0.74–2.03 | 0.42 | 0.78 | 0.44–1.41 | 0.42 |
Model 2 | 1 | 1.21 | 0.73–2.02 | 0.48 | 0.74 | 0.41–1.36 | 0.34 |
All-cause mortality | 95 | 63 | 62 | ||||
HR | HR | 95% CI | P | HR | 95% CI | P | |
Model 1 | 1 | 0.68 | 0.49–0.94 | 0.02 | 0.70 | 0.50–0.98 | 0.04 |
Model 2 | 1 | 1.45 | 1.05–2.00 | 0.03 | 1.39 | 1.00–1.95 | 0.05 |